The research focus of Prof. Volkamer is data driven drug design with expertise in method development and application.  The group develops methods at the interface of structural bioinformatics and cheminformatics with particular interest in structure-enabled machine learning approaches, applied in the context of computational drug design, especially kinase research, and in silico toxicology.

To further strengthen the location in the area of artificial intelligence to improve drug design, the groups of Andrea Volkamer, Andreas Keller, Rolf Müller, Anna Hirsch and Olga Kalinina are collaborating with the Saarland Informatics Campus and the German Research Center for Artificial Intelligence (NextAID project).